- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06248281
Be Cool: An Innovative and Holistic Psychoeducational Program for Multiple Sclerosis Individuals (BeCool)
Be Cool: An Innovative and Holistic Psychoeducational Program to Improve and Promote Care, Education and Quality of Life for Multiple Sclerosis Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fifteen individuals with multiple sclerosis will participate in an innovative, hybrid rehabilitation program, encompassing several key components to enhance their well-being. The program includes:
- Exercise Intervention: Participants will engage in specially designed exercise programs. Every two weeks, they will meet virtually with an exercise physiologist via Microsoft Teams for tailored education about their specific needs. Additionally, a customized exercise video will be uploaded weekly to the Teams platform, ensuring ongoing physical engagement.
- Nutritional Evaluation and Education: Nutrition is a core focus. A nutritionist will meet with the participants bi-weekly to discuss their dietary needs and educate them on maintaining a balanced diet to support their condition. Further enhancing this aspect, a nutritious recipe will be uploaded to the platform each week, offering practical dietary guidance.
- Psychological Support: Psychological well-being is addressed through weekly group meetings conducted by a psychologist. These sessions will utilize Acceptance and Commitment Therapy (ACT) strategies to help participants manage their symptoms, accept their condition, and improve their overall quality of life.
- Head and Neck Cooling Strategy: Recognizing the importance of temperature regulation in MS, participants will be advised to apply a cooling strategy to the head and neck area for at least two hours daily, providing symptomatic relief.
To monitor progress and adjust the program as needed, participants' functional ability, nutritional status, psychological condition, and overall quality of life will be evaluated at three key points: baseline (before starting the program), at the three-month mark, and upon completion of the program at six months.
This program is structured to provide a holistic, supportive, and adaptable approach to managing multiple sclerosis, focusing on physical health, nutritional balance, psychological support, and practical strategies for daily living.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Central Macedonia
-
Thessaloníki, Central Macedonia, Greece, 55132
- Greek Multiple Sclerosis Society
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participants must have been diagnosed with MS using the McDonald criteria, ensuring a standardized and validated diagnostic approach.
- Participants should have been relapse-free during the six months leading up to the study to avoid potential confounding factors.
- Participants must have no musculoskeletal impediment that could affect their ability to engage in the exercise component of the program.
- Participants must have a score on the Expanded Disability Status Scale (EDSS) ranging from 0 to 5.5, indicating ambulatory ability without the need for a cane for at least 100 meters.
- Participants should have a history of sensitivity to heat, as reported by their treating physician, justifying the need for cooling therapy as part of the hybrid program.
Participants must not have used cooling therapy or participated in any form of exercise training for at least four months prior to their participation in the study.
-
Exclusion Criteria:
- Previously diagnosed conditions known to impact physiological responses to heat exposure, including diabetes mellitus, hypertension, heart disease, or kidney disease.
Use of medications to manage MS-related symptoms, such as antidepressants, psychostimulants, anticonvulsants, antispasmodics, and anticholinergic drugs.
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Experimental group
The experimental group will attend a structured psychoeducational program developed to build and promote psychological flexibility.
In combination with this, participants of this group will have to follow a head and neck cooling protocol.
Also, participants of this group will be required to increase their habitual exercise levels and follow a video exercise program specifically designed for their needs and improve their nutrition based on the instructions of a nutritionist and videos specially designed for them.
|
The psychoeducational program will be conducted through weekly online video-conferencing group sessions that will last for two hours. In addition to these sessions, participants will receive psychoeducational material such as readings, videos, podcasts, worksheets, and homework exercises every week. This material will allow participants to practice at their own pace during the session intervals. The exercise training program for individuals with MS will be tailored to meet the unique and individual needs of each participant. To achieve this, a head and neck cooling protocol will be implemented using commercially available cooling equipment, specifically the Headcool Power and Neckcool Tie from Inuteq. Participants will need to wear the cooling cup and neck wrap for two hours daily. The equipment will be activated using 10°C tap water. Finally, a nutritionist will provide personalized nutritional guidance including weekly diet observation and recipe videos.
Other Names:
|
|
Control group
As per the study plan, the Control group has been designated as the control group.
They will continue with their normal lifestyle without any participation in rehabilitation activities or programs.
|
The psychoeducational program will be conducted through weekly online video-conferencing group sessions that will last for two hours. In addition to these sessions, participants will receive psychoeducational material such as readings, videos, podcasts, worksheets, and homework exercises every week. This material will allow participants to practice at their own pace during the session intervals. The exercise training program for individuals with MS will be tailored to meet the unique and individual needs of each participant. To achieve this, a head and neck cooling protocol will be implemented using commercially available cooling equipment, specifically the Headcool Power and Neckcool Tie from Inuteq. Participants will need to wear the cooling cup and neck wrap for two hours daily. The equipment will be activated using 10°C tap water. Finally, a nutritionist will provide personalized nutritional guidance including weekly diet observation and recipe videos.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anxiety and depression
Time Frame: Baseline, after three months and at the end of the six months
|
This will be estimated with the "The Hospital Anxiety and Depression Scale - HADS".
The Hospital Anxiety and Depression Scale (HADS) is a widely used questionnaire specifically designed to identify and measure the levels of anxiety and depression in individuals.
It is particularly useful in medical settings, as it helps distinguish between psychological distress and physical illness.
|
Baseline, after three months and at the end of the six months
|
|
Overall quality of life, namely satisfaction with their life
Time Frame: Baseline, after three months and at the end of the six months
|
This will be estimated with the questionnaire of Multiple Sclerosis Quality of Life-54 (MSQOL-54)
|
Baseline, after three months and at the end of the six months
|
|
Perception of stress
Time Frame: Baseline, after three months and at the end of the six months
|
Perceived Stress Scale (PSS) will be used.
This is a widely used psychological instrument for measuring the perception of stress.
It assesses the degree to which situations in one's life are appraised as stressful.
Items on the PSS ask about feelings and thoughts during the last month, and scores on the PSS can range from 0 to 40, with higher scores indicating higher perceived stress.
|
Baseline, after three months and at the end of the six months
|
|
Cognitive fusion which refers to the degree to which an individual's thoughts and feelings are intertwined with their sense of self, often leading to an inability to separate from, or 'defuse' from, these internal experiences.
Time Frame: Baseline, after three months and at the end of the six months
|
The Cognitive Fusion Questionnaire (CFQ-7) questionnaire that measures cognitive fusion, which a key concept in Acceptance and Commitment Therapy (ACT) will be used.
The CFQ-7, with its 7 items, assesses the extent to which a person experiences this phenomenon.
|
Baseline, after three months and at the end of the six months
|
|
The value of living
Time Frame: Baseline, after three months and at the end of the six months
|
The Valued Living Questionnaire (VLQ) will be used.
The VLQ is designed to assess valued living, which is another core concept in ACT.
It helps individuals to identify what is truly important and meaningful to them in various domains of life (such as family, career, health) and to what extent they have been living in accordance with these values.
|
Baseline, after three months and at the end of the six months
|
|
Psychological flexibility which is the ability to be in the present moment with full awareness and openness to experiences, and to take action guided by one's values.
Time Frame: Baseline, after three months and at the end of the six months
|
The MPFI-Psychological Flexibility Subscale will be used.
This subscale is part of a larger questionnaire and specifically measures psychological flexibility, an essential aspect of mental health and well-being.
|
Baseline, after three months and at the end of the six months
|
|
The resilience which is defined as the ability to cope with and bounce back from adversity.
Time Frame: Baseline, after three months and at the end of the six months
|
The Connor-Davidson Resilience Scale (CDRISC-25) will be used.
This 25-item scale measures resilience, defined as the ability to cope with and bounce back from adversity.
Higher scores indicate greater resilience.
|
Baseline, after three months and at the end of the six months
|
|
Aerobic capacity and ability to walk
Time Frame: Baseline, after three months and at the end of the six months
|
The Two Minute Walk Test (2MWT) is a simple, easy-to-administer functional exercise test used primarily in clinical settings.
It measures the distance an individual is able to walk on a flat, hard surface in a period of two minutes.
|
Baseline, after three months and at the end of the six months
|
|
Lower body strength and functional mobility
Time Frame: Baseline, after three months and at the end of the six months
|
The Five Times Sit to Stand Test (5xSST) will be used which is a simple yet effective physical performance test used primarily to assess lower body strength and functional mobility.
The test involves timing how long it takes an individual to stand up and sit down five times as quickly as possible from a standard height chair without using their arms for support.
A longer time to complete the test generally indicates lower functional performance.
|
Baseline, after three months and at the end of the six months
|
|
Static and dynamic balance ability
Time Frame: Baseline, after three months and at the end of the six months
|
The Berg Balance Scale (BBS) will be used which is a widely used clinical test of a person's static and dynamic balance abilities.
It is particularly common in elderly populations and among those recovering from injury or dealing with conditions that affect balance.
|
Baseline, after three months and at the end of the six months
|
|
Mobility and walking speed
Time Frame: Baseline, after three months and at the end of the six months
|
The Timed 25-Foot Walk (T25-FW) will be used which is a functional test commonly used to assess mobility and walking speed in individuals, particularly those with neurological conditions such as multiple sclerosis (MS).The test involves timing how quickly a person can walk 25 feet at their usual pace, usually conducted along a flat, straight course.
|
Baseline, after three months and at the end of the six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Finger dexterity and arm-hand coordination
Time Frame: Baseline, after three months and at the end of the six months
|
The 9-Hole Peg Test (9-HPT) will be used which is a standardized, widely used assessment tool in clinical and research settings to measure finger dexterity and arm-hand coordination.
It's particularly useful for evaluating upper extremity function in individuals with neurological conditions, such as multiple sclerosis (MS) and stroke.
|
Baseline, after three months and at the end of the six months
|
|
Core temperature
Time Frame: Baseline, after three months and at the end of the six months
|
With a gastrointestinal telemetric capsule (e-Celsius)
|
Baseline, after three months and at the end of the six months
|
|
Skin temperature
Time Frame: Baseline, after three months and at the end of the six months
|
iButtons
|
Baseline, after three months and at the end of the six months
|
|
Nutritional status, how balance is their nutrition
Time Frame: Baseline, after three months and at the end of the six months
|
This will be estimated with questionnaires
|
Baseline, after three months and at the end of the six months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Anastasios Orologas, MD, PhD, Greek Multiple Sclerosis Society
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 396/23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on combination of different rehabilitation strategies
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health...CompletedHIVUnited States, Puerto Rico
-
Karolinska InstitutetAddis Ababa UniversityUnknownAcquired Immunodeficiency Syndrome | TuberculosisEthiopia
-
University of AarhusCompleted
-
The First Affiliated Hospital with Nanjing Medical...RecruitingCoronary Heart DiseaseChina
-
Herning HospitalCompletedRehabilitationDenmark
-
Hospital Clinic of BarcelonaUniversity of BarcelonaCompleted
-
Georgia State UniversityNational Athletic Trainers' Association Research & Education Foundation (NATA...CompletedChronic Ankle Instability | Ankle Sprains | Ankle RehabilitationUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...CompletedPain, Postoperative | Erector Spinae Plane Block | Thoracic Surgery, Video-Assisted | Thoracic Paravertebral BlockTurkey
-
Centre Francois BaclesseGRECANCompleted